MC stabilizers such as SCG may alleviate hyperuricemia-induced renal fibrosis by inhibiting the recruitment of MCs and suppressing the TGF-β1/Smad2/3 pathway, and attenuate mitochondrial structural damage and relieve renal oxidative stress by inhibiting the production of Ang II. The gene discussed is SMAD2; the disease is hyperuricemia.